| Literature DB >> 35343761 |
Michel Abanto Marin1, Benjamín Leyton-Carcaman1, Claudio Vázquez1, Benjamín Durán-Vinet1,2, Katterin Bobadilla3, Claudio Rodriguez-Ruiz4, Andrés San Martín4, Pía Riquelme3, Fernando Baez3, María José Carrasco3, Gloria Rodríguez-Moretti3, Álvaro Cerda5, Nicolás Saavedra6, María de la Luz Mora1.
Abstract
Here, we announce the genome sequences of 408 strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) obtained from nasopharyngeal swabs in the Araucanía Region, Southern Chile. The genomes obtained are valuable to expand the availability of useful genomic data for future epidemiological studies of SARS-CoV-2 in Chile and worldwide.Entities:
Year: 2022 PMID: 35343761 PMCID: PMC9022523 DOI: 10.1128/mra.00121-22
Source DB: PubMed Journal: Microbiol Resour Announc ISSN: 2576-098X
Genomic features of 408 SARS-CoV-2 clinical samples
| ID | Age (yrs) | Sex | Patient status | Vaccination history | Collection date | Lineage | Clade | WHO variant | GC content (%) | Genome completeness (%) | Mean depth of coverage (×) | GISAID ID | GenBank ID | SRA accession |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AR-UFRO-0001 | 47 | Female | Alive, not hospitalized | Two doses Sinovac | 05-08-21 | P.1.15 | 20J | Gamma | 37.77 | 99.25 | 1,723 | EPI_ISL_4510310 |
|
|
| AR-UFRO-0002 | 32 | Male | Alive, not hospitalized | Two doses Pfizer | 06-08-21 | C.37 | 21G | Lambda | 37.54 | 98.57 | 1,417 | EPI_ISL_4510311 |
|
|
| AR-UFRO-0003 | 68 | Female | Alive, not hospitalized | Two doses Sinovac | 05-08-21 | P.1.15 | 20J | Gamma | 37.96 | 99.76 | 2,100 | EPI_ISL_4510312 |
|
|
| AR-UFRO-0004 | 74 | Female | Hospitalized | One dose Sinovac | 07-08-21 | P.1.15 | 20J | Gamma | 37.43 | 98.31 | 1,609 | EPI_ISL_4510313 |
|
|
| AR-UFRO-0005 | 18 | Female | Alive, not hospitalized | Two doses Sinovac | 06-08-21 | P.1 | 20J | Not determined | 37.3 | 97.95 | 1,381 | EPI_ISL_4510314 |
|
|
| AR-UFRO-0006 | 30 | Female | Alive, not hospitalized | Two doses Sinovac | 06-08-21 | C.37 | 21G | Lambda | 37.93 | 99.72 | 1,564 | EPI_ISL_4510315 |
|
|
| AR-UFRO-0007 | 70 | Male | Alive, not hospitalized | Not vaccinated | 06-08-21 | P.1 | 20J | Gamma | 37.93 | 99.68 | 2,111 | EPI_ISL_4510316 |
|
|
| AR-UFRO-0008 | 79 | Female | Alive, not hospitalized | Two doses Sinovac | 08-08-21 | P.1 | 20J | Gamma | 37.94 | 99.72 | 2,070 | EPI_ISL_4510317 |
|
|
| AR-UFRO-0009 | 68 | Female | Alive, not hospitalized | Two doses Sinovac | 07-08-21 | P.1 | 20J | Gamma | 37.91 | 99.52 | 1,730 | EPI_ISL_4510318 |
|
|
| AR-UFRO-0010 | 73 | Male | Alive, not hospitalized | Two doses Sinovac | 07-08-21 | P.1 | 20J | Gamma | 37.66 | 98.85 | 1,426 | EPI_ISL_4510319 |
|
|
| AR-UFRO-0011 | 18 | Male | Alive, not hospitalized | Not vaccinated | 06-08-21 | B.1.621 | 21H | Mu | 37.96 | 99.71 | 1,596 | EPI_ISL_4555339 |
|
|
| AR-UFRO-0012 | 42 | Female | Alive, not hospitalized | Not vaccinated | 06-08-21 | P.1.15 | 20J | Gamma | 37.64 | 98.76 | 1,666 | EPI_ISL_4510320 |
|
|
| AR-UFRO-0013 | 18 | Male | Alive, not hospitalized | One dose Sinovac | 06-08-21 | P.1.15 | 20J | Gamma | 37.4 | 98.11 | 1,543 | EPI_ISL_4510321 |
|
|
| AR-UFRO-0014 | 51 | Male | Alive, not hospitalized | Two doses Sinovac | 06-08-21 | P.1.15 | 20J | Gamma | 35.12 | 91.4 | 235 | EPI_ISL_4510322 |
|
|
| AR-UFRO-0015 | 33 | Female | Alive, not hospitalized | Two doses Sinovac | 07-08-21 | P.1.15 | 20J | Gamma | 37.63 | 98.89 | 1,816 | EPI_ISL_4510323 |
|
|
| AR-UFRO-0016 | 69 | Female | Alive, not hospitalized | Two doses Sinovac | 08-08-21 | P.1 | 20J | Gamma | 37.91 | 99.54 | 1,672 | EPI_ISL_4510324 |
|
|
| AR-UFRO-0017 | 48 | Male | Alive, not hospitalized | Two doses Sinovac | 08-08-21 | P.1.15 | 20J | Gamma | 37.84 | 99.38 | 1,784 | EPI_ISL_4510325 |
|
|
| AR-UFRO-0018 | 89 | Male | Asymptomatic | Two doses Sinovac | 06-08-21 | P.1 | 20J | Gamma | 36.57 | 95.8 | 1,608 | EPI_ISL_4510326 |
|
|
| AR-UFRO-0019 | 75 | Male | Asymptomatic | Two doses Sinovac | 06-08-21 | P.1 | 20J | Gamma | 37.81 | 99.34 | 1,955 | EPI_ISL_4510327 |
|
|
| AR-UFRO-0020 | 24 | Male | Alive, not hospitalized | Two doses Sinovac | 21-09-21 | P.1 | 20J | Gamma | 37.84 | 99.48 | 2,793 | EPI_ISL_4957754 |
|
|
| AR-UFRO-0021 | 26 | Female | Alive, not hospitalized | Two doses Sinovac | 21-09-21 | P.1 | 20J | Gamma | 37.93 | 99.73 | 2,977 | EPI_ISL_4957755 |
|
|
| AR-UFRO-0022 | 29 | Male | Alive, not hospitalized | Two doses Pfizer | 21-09-21 | AY.25.1 | 21J | Delta | 37.7 | 98.91 | 2,165 | EPI_ISL_4957759 |
|
|
| AR-UFRO-0023 | 35 | Male | Alive, not hospitalized | Two doses Sinovac | 21-09-21 | AY.25.1 | 21J | Delta | 36.88 | 96.7 | 1,348 | EPI_ISL_4957758 |
|
|
| AR-UFRO-0024 | 43 | Male | Alive, not hospitalized | Two doses Sinovac | 23-09-21 | AY.43 | 21J | Delta | 36.47 | 95.52 | 1,397 | EPI_ISL_4985032 |
|
|
| AR-UFRO-0025 | 38 | Male | Hospitalized | One dose Sinovac | 23-09-21 | AY.43 | 21J | Delta | 37.03 | 97.17 | 1,055 | EPI_ISL_4985043 |
|
|
| AR-UFRO-0026 | 38 | Female | Alive, not hospitalized | Two doses Sinovac | 24-09-21 | AY.25.1 | 21J | Delta | 37.26 | 97.79 | 1,679 | EPI_ISL_4985047 |
|
|
| AR-UFRO-0027 | 37 | Male | Alive, not hospitalized | Two doses Pfizer | 24-09-21 | AY.122 | 21J | Delta | 37.97 | 99.75 | 3,051 | EPI_ISL_5071343 |
|
|
| AR-UFRO-0028 | 51 | Male | Alive, not hospitalized | Two doses Pfizer | 24-09-21 | AY.122 | 21J | Delta | 37.97 | 99.72 | 2,660 | EPI_ISL_5071344 |
|
|
| AR-UFRO-0029 | 46 | Female | Alive, not hospitalized | Two doses Sinovac | 24-09-21 | AY.101 | 21J | Delta | 37.35 | 97.99 | 1,479 | EPI_ISL_4957756 |
|
|
| AR-UFRO-0030 | 49 | Male | Alive, not hospitalized | Two doses Sinovac | 24-09-21 | B.1.621 | 21H | Mu | 37.94 | 99.72 | 2,441 | EPI_ISL_4985069 |
|
|
| AR-UFRO-0031 | 17 | Female | Alive, not hospitalized | Not vaccinated | 24-09-21 | AY.25.1 | 21J | Delta | 37.56 | 98.6 | 2,243 | EPI_ISL_4985057 |
|
|
| AR-UFRO-0032 | 62 | Female | Hospitalized | Not vaccinated | 26-09-21 | AY.101 | 21J | Delta | 37.95 | 99.75 | 2,779 | EPI_ISL_4957757 |
|
|
| AR-UFRO-0034 | 24 | Female | Alive, not hospitalized | Two doses Sinovac | 26-09-21 | AY.25.1 | 21J | Delta | 37.97 | 99.74 | 2,475 | EPI_ISL_4957751 |
|
|
| AR-UFRO-0035 | 58 | Male | Alive, not hospitalized | Two doses Sinovac and one dose Pfizer | 28-09-21 | AY.25.1 | 21J | Delta | 37.97 | 99.74 | 3,229 | EPI_ISL_4957760 |
|
|
| AR-UFRO-0036 | 11 | Female | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 35.82 | 94.09 | 1,256 | EPI_ISL_4957761 |
|
|
| AR-UFRO-0037 | 65 | Male | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 36.22 | 94.77 | 1,186 | EPI_ISL_4957762 |
|
|
| AR-UFRO-0039 | 58 | Female | Alive, not hospitalized | Two doses Pfizer | 28-09-21 | AY.25.1 | 21J | Delta | 34.96 | 91.36 | 9,53 | EPI_ISL_4957763 |
|
|
| AR-UFRO-0040 | 35 | Female | Alive, not hospitalized | Two doses Pfizer | 28-09-21 | AY.25.1 | 21J | Delta | 27.87 | 72.17 | 214 | EPI_ISL_4957764 |
|
|
| AR-UFRO-0041 | 38 | Male | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 37.93 | 99.61 | 2,318 | EPI_ISL_4957765 |
|
|
| AR-UFRO-0048 | 61 | Female | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.17 | 97.45 | 1,037 | EPI_ISL_5071290 |
|
|
| AR-UFRO-0050 | 55 | Female | Alive, not hospitalized | Two doses Pfizer | 30-09-21 | AY.25.1 | 21J | Delta | 36.9 | 96.64 | 959 | EPI_ISL_5071291 |
|
|
| AR-UFRO-0051 | 25 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 36.64 | 96 | 838 | EPI_ISL_5071292 |
|
|
| AR-UFRO-0052 | 50 | Female | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.59 | 98.62 | 1,536 | EPI_ISL_5071293 |
|
|
| AR-UFRO-0053 | 56 | Male | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.37 | 98.04 | 1,267 | EPI_ISL_5071294 |
|
|
| AR-UFRO-0054 | 13 | Male | Alive, not hospitalized | One dose Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.43 | 98.2 | 1,083 | EPI_ISL_5071295 |
|
|
| AR-UFRO-0055 | 43 | Female | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.16 | 97.46 | 1,081 | EPI_ISL_5071296 |
|
|
| AR-UFRO-0056 | 12 | Female | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.03 | 97.16 | 1,331 | EPI_ISL_5071297 |
|
|
| AR-UFRO-0057 | 10 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.31 | 97.87 | 1,399 | EPI_ISL_5071298 |
|
|
| AR-UFRO-0058 | 22 | Male | Alive, not hospitalized | One dose Sinovac | 30-09-21 | AY.122 | 21J | Delta | 37 | 97.09 | 865 | EPI_ISL_5071299 |
|
|
| AR-UFRO-0060 | 2 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.02 | 97.02 | 1,146 | EPI_ISL_5071300 |
|
|
| AR-UFRO-0061 | 7 | Female | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.101 | 21J | Delta | 27.48 | 71.23 | 117 | EPI_ISL_5071301 |
|
|
| AR-UFRO-0062 | 10 | Female | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.101 | 21J | Delta | 27.97 | 72.37 | 209 | EPI_ISL_5071302 |
|
|
| AR-UFRO-0064 | 38 | Female | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 36.99 | 96.95 | 827 | EPI_ISL_5071303 |
|
|
| AR-UFRO-0065 | 42 | Female | Alive, not hospitalized | Two doses Sinovac | 01-10-21 | AY.100 | 21J | Delta | 28.41 | 73.88 | 280 | EPI_ISL_5071304 |
|
|
| AR-UFRO-0066 | 66 | Female | Alive, not hospitalized | Two doses Pfizer | 01-10-21 | AY.101 | 21J | Delta | 36.82 | 96.47 | 1,141 | EPI_ISL_5071305 |
|
|
| AR-UFRO-0067 | 68 | Female | Alive, not hospitalized | Not vaccinated | 01-10-21 | AY.101 | 21J | Delta | 34 | 89.41 | 643 | EPI_ISL_5071306 |
|
|
| AR-UFRO-0068 | 62 | Male | Alive, not hospitalized | Two doses Pfizer | 01-10-21 | AY.25.1 | 21J | Delta | 37.17 | 97.48 | 1,169 | EPI_ISL_5071307 |
|
|
| AR-UFRO-0069 | 26 | Male | Alive, not hospitalized | Not vaccinated | 01-10-21 | AY.101 | 21J | Delta | 30.24 | 78.68 | 670 | EPI_ISL_5071308 |
|
|
| AR-UFRO-0071 | 73 | Female | Alive, not hospitalized | Two doses Sinovac | 02-10-21 | AY.25.1 | 21J | Delta | 37.53 | 98.4 | 1,159 | EPI_ISL_5071309 |
|
|
| AR-UFRO-0074 | 28 | Female | Alive, not hospitalized | Two doses Pfizer | 03-10-21 | AY.25.1 | 21J | Delta | 37.37 | 97.99 | 1,691 | EPI_ISL_5071310 |
|
|
| AR-UFRO-0075 | 39 | Male | Alive, not hospitalized | Two doses Pfizer | 03-10-21 | AY.25.1 | 21J | Delta | 37.23 | 97.65 | 1,277 | EPI_ISL_5071311 |
|
|
| AR-UFRO-0076 | 31 | Male | Alive, not hospitalized | Two doses Sinovac | 01-10-21 | AY.25.1 | 21J | Delta | 37.39 | 98.13 | 1,903 | EPI_ISL_5071312 |
|
|
| AR-UFRO-0077 | 62 | Male | Alive, not hospitalized | Two doses Sinovac | 29-09-21 | AY.122 | 21J | Delta | 37.46 | 98.3 | 1,589 | EPI_ISL_5071313 |
|
|
| AR-UFRO-0078 | 47 | Male | Alive, not hospitalized | Two doses Sinovac | 27-09-21 | AY.101 | 21J | Delta | 37.22 | 97.64 | 768 | EPI_ISL_5071314 |
|
|
| AR-UFRO-0079 | 14 | Male | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 37.35 | 98 | 1,166 | EPI_ISL_5071315 |
|
|
| AR-UFRO-0080 | 47 | Female | Asymptomatic | Two doses Sinovac | 27-09-21 | AY.25.1 | 21J | Delta | 37.17 | 97.46 | 1,154 | EPI_ISL_5071316 |
|
|
| AR-UFRO-0081 | 45 | Female | Alive, not hospitalized | Two doses Sinovac | 28-09-21 | AY.25.1 | 21J | Delta | 36.93 | 97.01 | 985 | EPI_ISL_5071317 |
|
|
| AR-UFRO-0082 | 33 | Female | Alive, not hospitalized | Not vaccinated | 29-09-21 | AY.101 | 21J | Delta | 36.73 | 96.31 | 798 | EPI_ISL_5071318 |
|
|
| AR-UFRO-0083 | 21 | Male | Alive, not hospitalized | Not vaccinated | 29-09-21 | AY.25.1 | 21J | Delta | 37.29 | 97.75 | 895 | EPI_ISL_5071319 |
|
|
| AR-UFRO-0084 | 80 | Female | Hospitalized | Two doses Sinovac | 29-09-21 | B.1.621 | 21H | Mu | 37.58 | 98.73 | 1,150 | EPI_ISL_5094642 |
|
|
| AR-UFRO-0085 | 14 | Female | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.101 | 21J | Delta | 31.89 | 83.24 | 439 | EPI_ISL_5071320 |
|
|
| AR-UFRO-0086 | 47 | Female | Alive, not hospitalized | Two doses Sinovac | 29-09-21 | AY.25.1 | 21J | Delta | 37.41 | 98.09 | 1,480 | EPI_ISL_5071321 |
|
|
| AR-UFRO-0087 | 31 | Female | Alive, not hospitalized | Two doses Pfizer | 29-09-21 | AY.25.1 | 21J | Delta | 37.67 | 98.87 | 1,551 | EPI_ISL_5071322 |
|
|
| AR-UFRO-0088 | 27 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.17 | 97.47 | 1,288 | EPI_ISL_5071323 |
|
|
| AR-UFRO-0089 | 10 | Female | Asymptomatic | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.64 | 98.78 | 1,539 | EPI_ISL_5071324 |
|
|
| AR-UFRO-0090 | 7 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.39 | 98.07 | 1,601 | EPI_ISL_5071325 |
|
|
| AR-UFRO-0091 | 12 | Male | Alive, not hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 37.67 | 98.85 | 1,427 | EPI_ISL_5071326 |
|
|
| AR-UFRO-0092 | 28 | Male | Alive, not hospitalized | Not vaccinated | 28-09-21 | P.1 | 20J | Gamma | 37.84 | 99.37 | 1,221 | EPI_ISL_5071327 |
|
|
| AR-UFRO-0093 | 47 | Female | Alive, not hospitalized | Two doses Sinovac | 29-09-21 | AY.25.1 | 21J | Delta | 37.1 | 97.23 | 1,585 | EPI_ISL_5071328 |
|
|
| AR-UFRO-0095 | 27 | Female | Alive, not hospitalized | Two doses Sinovac | 29-09-21 | P.1 | 20J | Gamma | 37.85 | 99.49 | 1,226 | EPI_ISL_5071329 |
|
|
| AR-UFRO-0096 | 12 | Male | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.3 | 97.92 | 1,567 | EPI_ISL_5071330 |
|
|
| AR-UFRO-0097 | 48 | Male | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.06 | 97.1 | 869 | EPI_ISL_5071331 |
|
|
| AR-UFRO-0098 | 57 | Female | Alive, not hospitalized | Two doses Sinovac | 30-09-21 | AY.25.1 | 21J | Delta | 37.66 | 98.88 | 1,595 | EPI_ISL_5071332 |
|
|
| AR-UFRO-0099 | 11 | Female | Alive, not hospitalized | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.21 | 97.55 | 1,539 | EPI_ISL_5071333 |
|
|
| AR-UFRO-0100 | 25 | Male | Alive, not hospitalized | Two doses Sinovac | 29-09-21 | AY.25.1 | 21J | Delta | 37.32 | 97.9 | 919 | EPI_ISL_5071334 |
|
|
| AR-UFRO-0101 | 9 | Female | Asymptomatic | Not vaccinated | 30-09-21 | AY.25.1 | 21J | Delta | 37.18 | 97.57 | 1,486 | EPI_ISL_5071335 |
|
|
| AR-UFRO-0102 | 22 | Female | Alive, not hospitalized | Two doses Sinovac | 01-10-21 | AY.25.1 | 21J | Delta | 37.19 | 97.48 | 897 | EPI_ISL_5071336 |
|
|
| AR-UFRO-0103 | 67 | Male | Alive, not hospitalized | Two doses Sinovac | 28-09-21 | AY.25.1 | 21J | Delta | 37.17 | 97.45 | 1,283 | EPI_ISL_5071337 |
|
|
| AR-UFRO-0104 | 28 | Female | Alive, not hospitalized | Two doses Sinovac | 01-10-21 | AY.43.3 | 21J | Delta | 37.77 | 99.18 | 1,696 | EPI_ISL_5071338 |
|
|
| AR-UFRO-0105 | 32 | Male | Alive, not hospitalized | Two doses Sinovac | 01-10-21 | B.1.621 | 21H | Mu | 37.94 | 99.73 | 1,322 | EPI_ISL_5094643 |
|
|
| AR-UFRO-0106 | 35 | Female | Alive, not hospitalized | Not vaccinated | 30-09-21 | B.1.621 | 21H | Mu | 37.68 | 98.95 | 1,167 | EPI_ISL_5094644 |
|
|
| AR-UFRO-0107 | 59 | Female | Alive, not hospitalized | Not vaccinated | 02-10-21 | AY.25.1 | 21J | Delta | 37.24 | 97.57 | 850 | EPI_ISL_5071339 |
|
|
| AR-UFRO-0108 | 59 | Male | Alive, not hospitalized | Two doses Pfizer | 02-10-21 | AY.43.3 | 21J | Delta | 37.66 | 98.87 | 1,853 | EPI_ISL_5071340 |
|
|
| AR-UFRO-0109 | 27 | Male | Alive, not hospitalized | Two doses Sinovac | 03-10-21 | AY.100 | 21J | Delta | 37.64 | 98.88 | 1,748 | EPI_ISL_5071341 |
|
|
| AR-UFRO-0110 | 29 | Female | Alive, not hospitalized | Two doses Sinovac | 03-10-21 | AY.100 | 21J | Delta | 37.62 | 98.84 | 1,524 | EPI_ISL_5094645 |
|
|
| AR-UFRO-0111 | 18 | Female | Asymptomatic | Two doses Pfizer | 03-10-21 | AY.25.1 | 21J | Delta | 37.26 | 97.71 | 1,173 | EPI_ISL_5071342 |
|
|
| AR-UFRO-0113 | 6 | Female | Alive, not hospitalized | Not vaccinated | 07-10-21 | AY.25.1 | 21J | Delta | 36.65 | 95.74 | 172 | EPI_ISL_5294205 |
|
|
| AR-UFRO-0114 | 9 | Female | Alive, not hospitalized | Not vaccinated | 08-10-21 | AY.25.1 | 21J | Delta | 36.56 | 95.74 | 155 | EPI_ISL_5294213 |
|
|
| AR-UFRO-0115 | 56 | Female | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.75 | 21J | Delta | 30.38 | 78.76 | 47 | EPI_ISL_5294221 |
|
|
| AR-UFRO-0116 | 85 | Male | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.25.1 | 21J | Delta | 36.89 | 96.51 | 236 | EPI_ISL_5294229 |
|
|
| AR-UFRO-0117 | 52 | Female | Alive, not hospitalized | Two doses Sinovac | 09-10-21 | AY.25.1 | 21J | Delta | 33.52 | 87.45 | 113 | EPI_ISL_5294233 |
|
|
| AR-UFRO-0118 | 38 | Male | Alive, not hospitalized | Two doses Sinovac | 09-10-21 | AY.25.1 | 21J | Delta | 36.59 | 95.87 | 172 | EPI_ISL_5294241 |
|
|
| AR-UFRO-0119 | 2 | Female | Alive, not hospitalized | Not vaccinated | 04-10-21 | AY.25.1 | 21J | Delta | 37.14 | 97.31 | 172 | EPI_ISL_5294246 |
|
|
| AR-UFRO-0120 | 25 | Female | Alive, not hospitalized | Two doses Sinovac | 04-10-21 | AY.25.1 | 21J | Delta | 37.14 | 97.38 | 309 | EPI_ISL_5294251 |
|
|
| AR-UFRO-0121 | 29 | Female | Alive, not hospitalized | Two doses Sinovac | 04-10-21 | AY.25.1 | 21J | Delta | 37.03 | 97.01 | 226 | EPI_ISL_5294258 |
|
|
| AR-UFRO-0122 | 37 | Female | Alive, not hospitalized | Two doses Sinovac | 04-10-21 | AY.43.3 | 21J | Delta | 37.14 | 97.31 | 292 | EPI_ISL_5294264 |
|
|
| AR-UFRO-0123 | 32 | Female | Alive, not hospitalized | Two doses Sinovac | 04-10-21 | AY.25.1 | 21J | Delta | 36.88 | 96.58 | 217 | EPI_ISL_5294272 |
|
|
| AR-UFRO-0124 | 45 | Male | Alive, not hospitalized | One dose AstraZeneca and one dose Pfizer | 04-10-21 | AY.25.1 | 21J | Delta | 36.68 | 96.07 | 215 | EPI_ISL_5315247 |
|
|
| AR-UFRO-0125 | 10 | Female | Alive, not hospitalized | Not vaccinated | 04-10-21 | AY.25.1 | 21J | Delta | 36.88 | 96.6 | 299 | EPI_ISL_5294277 |
|
|
| AR-UFRO-0126 | 52 | Male | Alive, not hospitalized | Two doses Sinovac | 06-10-21 | AY.25.1 | 21J | Delta | 36.87 | 96.58 | 251 | EPI_ISL_5294284 |
|
|
| AR-UFRO-0127 | 31 | Female | Alive, not hospitalized | Two doses Sinovac | 06-10-21 | AY.100 | 21J | Delta | 36.39 | 95.08 | 103 | EPI_ISL_5294290 |
|
|
| AR-UFRO-0128 | 66 | Female | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.43.3 | 21J | Delta | 37.12 | 97.33 | 264 | EPI_ISL_5294297 |
|
|
| AR-UFRO-0129 | 73 | Male | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.43 | 21J | Delta | 29.85 | 77.73 | 55 | EPI_ISL_5294301 |
|
|
| AR-UFRO-0130 | 28 | Male | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.43.3 | 21J | Delta | 37.53 | 98.42 | 271 | EPI_ISL_5294308 |
|
|
| AR-UFRO-0131 | 30 | Female | Alive, not hospitalized | Two doses Pfizer | 05-10-21 | AY.25.1 | 21J | Delta | 36.53 | 95.5 | 203 | EPI_ISL_5294318 |
|
|
| AR-UFRO-0132 | 13 | Female | Alive, not hospitalized | Not vaccinated | 05-10-21 | AY.25.1 | 21J | Delta | 37.19 | 97.53 | 297 | EPI_ISL_5294320 |
|
|
| AR-UFRO-0133 | 69 | Female | Alive, not hospitalized | Two doses Sinovac | 04-10-21 | AY.122 | 21J | Delta | 36.6 | 95.75 | 238 | EPI_ISL_5294328 |
|
|
| AR-UFRO-0135 | 58 | Female | Alive, not hospitalized | Two doses Sinovac | 05-10-21 | AY.25.1 | 21J | Delta | 37.14 | 97.35 | 199 | EPI_ISL_5294331 |
|
|
| AR-UFRO-0136 | 66 | Male | Alive, not hospitalized | Two doses Sinovac | 05-10-21 | AY.25.1 | 21J | Delta | 35.26 | 92.08 | 150 | EPI_ISL_5294337 |
|
|
| AR-UFRO-0137 | 39 | Female | Alive, not hospitalized | Two doses Sinovac | 06-10-21 | AY.25.1 | 21J | Delta | 37.04 | 97.02 | 252 | EPI_ISL_5294345 |
|
|
| AR-UFRO-0138 | 32 | Male | Alive, not hospitalized | Two doses Sinovac | 06-10-21 | AY.25.1 | 21J | Delta | 37.15 | 97.38 | 274 | EPI_ISL_5294355 |
|
|
| AR-UFRO-0139 | 9 | Male | Alive, not hospitalized | Not vaccinated | 07-10-21 | B.1.621 | 21H | Mu | 37.33 | 97.94 | 282 | EPI_ISL_5315248 |
|
|
| AR-UFRO-0140 | 46 | Female | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.25.1 | 21J | Delta | 36.89 | 96.47 | 144 | EPI_ISL_5294365 |
|
|
| AR-UFRO-0141 | 39 | Male | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.43 | 21J | Delta | 35.99 | 94.24 | 155 | EPI_ISL_5294374 |
|
|
| AR-UFRO-0142 | 24 | Female | Alive, not hospitalized | Two doses Pfizer | 08-10-21 | AY.43 | 21J | Delta | 37.37 | 97.98 | 239 | EPI_ISL_5315249 |
|
|
| AR-UFRO-0143 | 81 | Female | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.43 | 21J | Delta | 33.84 | 88.3 | 83 | EPI_ISL_5294381 |
|
|
| AR-UFRO-0144 | 30 | Male | Alive, not hospitalized | Not vaccinated | 07-10-21 | AY.100 | 21J | Delta | 37.11 | 97.37 | 248 | EPI_ISL_5294388 |
|
|
| AR-UFRO-0145 | 60 | Female | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.43.3 | 21J | Delta | 37.16 | 97.48 | 289 | EPI_ISL_5294396 |
|
|
| AR-UFRO-0146 | 70 | Male | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.122 | 21J | Delta | 37.41 | 98.2 | 340 | EPI_ISL_5294404 |
|
|
| AR-UFRO-0148 | 57 | Female | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.43.3 | 21J | Delta | 36.34 | 95.14 | 216 | EPI_ISL_5294412 |
|
|
| AR-UFRO-0149 | 28 | Female | Alive, not hospitalized | Two doses Pfizer | 06-10-21 | AY.122 | 21J | Delta | 37.11 | 97.38 | 335 | EPI_ISL_5294419 |
|
|
| AR-UFRO-0150 | 24 | Male | Alive, not hospitalized | Not vaccinated | 05-10-21 | AY.43 | 21J | Delta | 29.13 | 74.74 | 47 | EPI_ISL_5294424 |
|
|
| AR-UFRO-0151 | 36 | Male | Alive, not hospitalized | Two doses Sinovac | 05-10-21 | AY.25.1 | 21J | Delta | 37.15 | 97.4 | 210 | EPI_ISL_5294430 |
|
|
| AR-UFRO-0152 | 74 | Male | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.122 | 21J | Delta | 31.37 | 81.89 | 87 | EPI_ISL_5294439 |
|
|
| AR-UFRO-0153 | 71 | Male | Alive, not hospitalized | Two doses Sinovac | 08-10-21 | AY.122 | 21J | Delta | 37.41 | 98.24 | 331 | EPI_ISL_5294445 |
|
|
| AR-UFRO-0154 | 33 | Female | Alive, not hospitalized | One dose Sinovac | 08-10-21 | AY.25.1 | 21J | Delta | 37.61 | 98.69 | 296 | EPI_ISL_5294453 |
|
|
| AR-UFRO-0155 | 50 | Female | Alive, not hospitalized | Two doses Sinovac | 07-10-21 | AY.25.1 | 21J | Delta | 36.17 | 94.68 | 274 | EPI_ISL_5294462 |
|
|
| AR-UFRO-0156 | 8 | Female | Alive, not hospitalized | Not vaccinated | 06-10-21 | AY.25.1 | 21J | Delta | 36.98 | 96.54 | 320 | EPI_ISL_5294471 |
|
|
| AR-UFRO-0157 | 21 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 37.13 | 97.35 | 283 | EPI_ISL_5294478 |
|
|
| AR-UFRO-0162 | 26 | Male | Alive, not hospitalized | Two doses Sinovac | 11-10-21 | B.1.617.2 | 21J | Delta | 25.34 | 65.72 | 35 | EPI_ISL_5294484 |
|
|
| AR-UFRO-0163 | 38 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 32.97 | 85.96 | 125 | EPI_ISL_5294488 |
|
|
| AR-UFRO-0164 | 76 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 34.87 | 91.56 | 166 | EPI_ISL_5294497 |
|
|
| AR-UFRO-0168 | 73 | Female | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 35.96 | 94.31 | 404 | EPI_ISL_5524302 |
|
|
| AR-UFRO-0169 | 14 | Female | Alive, not hospitalized | Not vaccinated | 13-10-21 | AY.25.1 | 21J | Delta | 37.59 | 98.67 | 1,170 | EPI_ISL_5524314 |
|
|
| AR-UFRO-0172 | 34 | Female | Alive, not hospitalized | Two doses Pfizer | 14-10-21 | AY.25.1 | 21J | Delta | 36.4 | 95.45 | 569 | EPI_ISL_5524327 |
|
|
| AR-UFRO-0174 | 57 | Female | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.101 | 21J | Delta | 37.66 | 98.93 | 1,038 | EPI_ISL_5524328 |
|
|
| AR-UFRO-0175 | 56 | Female | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.25.1 | 21J | Delta | 37.5 | 98.43 | 984 | EPI_ISL_5524329 |
|
|
| AR-UFRO-0176 | 77 | Male | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.20 | 21J | Delta | 35.46 | 92.91 | 329 | EPI_ISL_5524330 |
|
|
| AR-UFRO-0178 | 15 | Female | Alive, not hospitalized | Two doses Sinovac | 16-10-21 | AY.25.1 | 21J | Delta | 36.87 | 96.64 | 828 | EPI_ISL_5524345 |
|
|
| AR-UFRO-0179 | 63 | Female | Alive, not hospitalized | Not vaccinated | 16-10-21 | AY.25.1 | 21J | Delta | 31.82 | 83.24 | 90 | EPI_ISL_5524346 |
|
|
| AR-UFRO-0181 | 52 | Female | Alive, not hospitalized | Two doses Pfizer | 17-10-21 | AY.25.1 | 21J | Delta | 36.63 | 96.17 | 571 | EPI_ISL_5524348 |
|
|
| AR-UFRO-0182 | 26 | Female | Alive, not hospitalized | Two doses Pfizer | 18-10-21 | AY.122 | 21J | Delta | 37.76 | 99.14 | 1,070 | EPI_ISL_5524349 |
|
|
| AR-UFRO-0184 | 11 | Male | Alive, not hospitalized | One dose Sinovac | 18-10-21 | AY.25.1 | 21J | Delta | 36.93 | 96.82 | 917 | EPI_ISL_5524350 |
|
|
| AR-UFRO-0185 | 57 | Female | Alive, not hospitalized | Two doses Pfizer | 18-10-21 | AY.25.1 | 21J | Delta | 37.48 | 98.3 | 1,210 | EPI_ISL_5524351 |
|
|
| AR-UFRO-0186 | 81 | Female | Alive, not hospitalized | Two doses Sinovac | 18-10-21 | AY.25.1 | 21J | Delta | 36.16 | 94.78 | 772 | EPI_ISL_5524352 |
|
|
| AR-UFRO-0187 | 62 | Male | Alive, not hospitalized | Two doses Sinovac | 18-10-21 | AY.25.1 | 21J | Delta | 35.64 | 93.18 | 475 | EPI_ISL_5524353 |
|
|
| AR-UFRO-0188 | 14 | Female | Alive, not hospitalized | Not vaccinated | 18-10-21 | AY.129 | 21J | Delta | 35.47 | 93.03 | 422 | EPI_ISL_5524354 |
|
|
| AR-UFRO-0189 | 47 | Male | Alive, not hospitalized | One dose Sinovac | 18-10-21 | AY.20 | 21J | Delta | 37.95 | 99.74 | 1,239 | EPI_ISL_5524355 |
|
|
| AR-UFRO-0190 | 61 | Female | Alive, not hospitalized | Not vaccinated | 18-10-21 | AY.20 | 21J | Delta | 37.49 | 98.49 | 1,067 | EPI_ISL_5524356 |
|
|
| AR-UFRO-0191 | 24 | Male | Alive, not hospitalized | Two doses Sinovac | 19-10-21 | AY.25.1 | 21J | Delta | 37.48 | 98.34 | 1,183 | EPI_ISL_5524357 |
|
|
| AR-UFRO-0193 | 55 | Male | Alive, not hospitalized | Two doses Sinovac | 19-10-21 | AY.25.1 | 21J | Delta | 34.94 | 91.71 | 329 | EPI_ISL_5524358 |
|
|
| AR-UFRO-0194 | 32 | Male | Alive, not hospitalized | One dose AstraZeneca and one dose Pfizer | 19-10-21 | AY.25.1 | 21J | Delta | 36.07 | 94.48 | 431 | EPI_ISL_5524359 |
|
|
| AR-UFRO-0195 | 42 | Female | Hospitalized | Not vaccinated | 28-09-21 | AY.25.1 | 21J | Delta | 37.67 | 98.84 | 1,064 | EPI_ISL_5524299 |
|
|
| AR-UFRO-0196 | 48 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.43 | 21J | Delta | 37.67 | 98.84 | 1,143 | EPI_ISL_5866982 |
|
|
| AR-UFRO-0197 | 43 | Male | Alive, not hospitalized | Not vaccinated | 12-10-21 | AY.43.3 | 21J | Delta | 37.64 | 98.81 | 1,078 | EPI_ISL_5524303 |
|
|
| AR-UFRO-0198 | 24 | Male | Alive, not hospitalized | Two doses CanSino | 12-10-21 | AY.43.3 | 21J | Delta | 37.33 | 97.96 | 765 | EPI_ISL_5524304 |
|
|
| AR-UFRO-0199 | 46 | Female | Alive, not hospitalized | Two doses Sinovac | 11-10-21 | AY.25.1 | 21J | Delta | 36.35 | 95.43 | 650 | EPI_ISL_5524300 |
|
|
| AR-UFRO-0200 | 63 | Female | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.43.3 | 21J | Delta | 37.66 | 98.86 | 1,184 | EPI_ISL_5524305 |
|
|
| AR-UFRO-0201 | 32 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 37.6 | 98.59 | 861 | EPI_ISL_5524306 |
|
|
| AR-UFRO-0202 | 46 | Male | Alive, not hospitalized | Two doses Pfizer | 11-10-21 | B.1.621 | 21H | Mu | 37.97 | 99.74 | 1,168 | EPI_ISL_5866981 |
|
|
| AR-UFRO-0203 | 18 | Male | Alive, not hospitalized | Two doses CanSino | 12-10-21 | B.1.621 | 21H | Mu | 37.87 | 99.56 | 1,019 | EPI_ISL_5866983 |
|
|
| AR-UFRO-0204 | 30 | Male | Alive, not hospitalized | Not vaccinated | 11-10-21 | AY.100 | 21J | Delta | 37.8 | 99.36 | 1,359 | EPI_ISL_5524301 |
|
|
| AR-UFRO-0205 | 58 | Female | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.63 | 98.75 | 1,123 | EPI_ISL_5524315 |
|
|
| AR-UFRO-0206 | 30 | Male | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.25.1 | 21J | Delta | 37.48 | 98.35 | 1,115 | EPI_ISL_5524316 |
|
|
| AR-UFRO-0207 | 53 | Female | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.122 | 21J | Delta | 37.9 | 99.65 | 1,463 | EPI_ISL_5524331 |
|
|
| AR-UFRO-0208 | 22 | Female | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 37.16 | 97.14 | 873 | EPI_ISL_5524307 |
|
|
| AR-UFRO-0209 | 23 | Male | Alive, not hospitalized | Two doses CanSino | 12-10-21 | AY.25.1 | 21J | Delta | 36.18 | 94.48 | 502 | EPI_ISL_5524308 |
|
|
| AR-UFRO-0210 | 44 | Female | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.66 | 98.87 | 1,391 | EPI_ISL_5524317 |
|
|
| AR-UFRO-0211 | 42 | Male | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,046 | EPI_ISL_5524318 |
|
|
| AR-UFRO-0212 | 20 | Female | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,178 | EPI_ISL_5524319 |
|
|
| AR-UFRO-0213 | 44 | Female | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.45 | 98.24 | 898 | EPI_ISL_5524320 |
|
|
| AR-UFRO-0214 | 8 | Male | Alive, not hospitalized | One dose Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.36 | 98.02 | 937 | EPI_ISL_5524321 |
|
|
| AR-UFRO-0215 | 29 | Female | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,327 | EPI_ISL_5524309 |
|
|
| AR-UFRO-0216 | 49 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 37.68 | 98.85 | 1,137 | EPI_ISL_5524310 |
|
|
| AR-UFRO-0217 | 41 | Male | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.53 | 98.46 | 943 | EPI_ISL_5524322 |
|
|
| AR-UFRO-0218 | 48 | Female | Alive, not hospitalized | Two doses Pfizer | 12-10-21 | AY.43 | 21J | Delta | 37.43 | 98.23 | 994 | EPI_ISL_5866984 |
|
|
| AR-UFRO-0219 | 22 | Female | Alive, not hospitalized | Two doses Pfizer | 12-10-21 | AY.43 | 21J | Delta | 37.25 | 97.65 | 843 | EPI_ISL_5866985 |
|
|
| AR-UFRO-0220 | 31 | Female | Alive, not hospitalized | Not vaccinated | 12-10-21 | AY.122 | 21J | Delta | 37.64 | 98.85 | 1,252 | EPI_ISL_5524311 |
|
|
| AR-UFRO-0221 | 32 | Male | Alive, not hospitalized | Two doses Sinovac | 12-10-21 | AY.25.1 | 21J | Delta | 37.78 | 99.14 | 1,297 | EPI_ISL_5524312 |
|
|
| AR-UFRO-0222 | 59 | Male | Alive, not hospitalized | Not vaccinated | 12-10-21 | AY.25.1 | 21J | Delta | 36.92 | 96.57 | 794 | EPI_ISL_5524313 |
|
|
| AR-UFRO-0223 | 8 | Male | Alive, not hospitalized | Not vaccinated | 14-10-21 | AY.25.1 | 21J | Delta | 37.39 | 98.03 | 929 | EPI_ISL_5524332 |
|
|
| AR-UFRO-0225 | 7 | Male | Alive, not hospitalized | Not vaccinated | 14-10-21 | AY.25.1 | 21J | Delta | 37.67 | 98.84 | 1,047 | EPI_ISL_5524334 |
|
|
| AR-UFRO-0226 | 37 | Female | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.87 | 1,310 | EPI_ISL_5524335 |
|
|
| AR-UFRO-0227 | 12 | Male | Alive, not hospitalized | One dose Sinovac | 14-10-21 | B.1.621 | 21H | Mu | 37.96 | 99.72 | 1,308 | EPI_ISL_5866986 |
|
|
| AR-UFRO-0228 | 48 | Female | Alive, not hospitalized | Two doses Sinovac | 15-10-21 | AY.25.1 | 21J | Delta | 37.77 | 99.16 | 1,513 | EPI_ISL_5524340 |
|
|
| AR-UFRO-0229 | 27 | Male | Alive, not hospitalized | Two doses Sinovac | 15-10-21 | AY.25.1 | 21J | Delta | 37.05 | 97.12 | 688 | EPI_ISL_5524341 |
|
|
| AR-UFRO-0230 | 12 | Female | Alive, not hospitalized | One dose Pfizer | 14-10-21 | AY.43 | 21J | Delta | 37.15 | 97.58 | 618 | EPI_ISL_5524336 |
|
|
| AR-UFRO-0231 | 58 | Female | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.122 | 21J | Delta | 37.96 | 99.74 | 1,563 | EPI_ISL_5524337 |
|
|
| AR-UFRO-0232 | 65 | Male | Alive, not hospitalized | Two doses Sinovac | 14-10-21 | AY.122 | 21J | Delta | 37.81 | 99.35 | 1,453 | EPI_ISL_5524338 |
|
|
| AR-UFRO-0233 | 18 | Female | Alive, not hospitalized | Two doses Sinovac | 15-10-21 | AY.122 | 21J | Delta | 37.44 | 98.33 | 1,612 | EPI_ISL_5524342 |
|
|
| AR-UFRO-0234 | 43 | Male | Alive, not hospitalized | Not vaccinated | 15-10-21 | AY.122 | 21J | Delta | 37.52 | 98.61 | 1,335 | EPI_ISL_5524343 |
|
|
| AR-UFRO-0235 | 58 | Male | Alive, not hospitalized | Two doses Sinovac | 15-10-21 | AY.25.1 | 21J | Delta | 37.65 | 98.84 | 1,331 | EPI_ISL_5866987 |
|
|
| AR-UFRO-0236 | 51 | Female | Hospitalized | Two doses Sinovac | 15-10-21 | AY.25.1 | 21J | Delta | 37.66 | 98.85 | 1,529 | EPI_ISL_5524344 |
|
|
| AR-UFRO-0237 | 33 | Male | Alive, not hospitalized | Not vaccinated | 13-10-21 | AY.25.1 | 21J | Delta | 37.67 | 98.85 | 1,485 | EPI_ISL_5524323 |
|
|
| AR-UFRO-0238 | 75 | Male | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.25.1 | 21J | Delta | 29.19 | 75.03 | 869 | EPI_ISL_5524324 |
|
|
| AR-UFRO-0239 | 30 | Male | Alive, not hospitalized | One dose Sinovac | 14-10-21 | AY.25.1 | 21J | Delta | 37.38 | 98.06 | 1,040 | EPI_ISL_5524339 |
|
|
| AR-UFRO-0240 | 2 | Male | Alive, not hospitalized | Not vaccinated | 13-10-21 | AY.43.3 | 21J | Delta | 37.78 | 99.17 | 1,457 | EPI_ISL_5524325 |
|
|
| AR-UFRO-0241 | 22 | Female | Alive, not hospitalized | Two doses Sinovac | 13-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.86 | 1,551 | EPI_ISL_5524326 |
|
|
| AR-UFRO-0243 | 64 | Male | Hospitalized | Two doses Sinovac | 16-10-21 | AY.25.1 | 21J | Delta | 37.66 | 98.84 | 1,358 | EPI_ISL_5524347 |
|
|
| AR-UFRO-0245 | 20 | Male | Alive, not hospitalized | Two doses Sinovac | 19-10-21 | AY.122 | 21J | Delta | 35.74 | 93.6 | 667 | EPI_ISL_5881129 |
|
|
| AR-UFRO-0247 | 41 | Female | Alive, not hospitalized | Two doses Sinovac | 20-10-21 | AY.43.3 | 21J | Delta | 37.18 | 97.51 | 1,379 | EPI_ISL_5881139 |
|
|
| AR-UFRO-0249 | 7 | Female | Alive, not hospitalized | One dose Sinovac | 21-10-21 | AY.25.1 | 21J | Delta | 36.01 | 94.42 | 835 | EPI_ISL_5881128 |
|
|
| AR-UFRO-0250 | 4 | Male | Alive, not hospitalized | Not vaccinated | 21-10-21 | AY.25.1 | 21J | Delta | 37.4 | 98.23 | 1,724 | EPI_ISL_5881136 |
|
|
| AR-UFRO-0259 | 55 | Female | Alive, not hospitalized | Two doses Sinovac | 24-10-21 | AY.25.1 | 21J | Delta | 37.9 | 99.51 | 1,567 | EPI_ISL_5881108 |
|
|
| AR-UFRO-0260 | 63 | Male | Alive, not hospitalized | Two doses Sinovac | 24-10-21 | AY.25.1 | 21J | Delta | 37.81 | 99.28 | 1,830 | EPI_ISL_5881109 |
|
|
| AR-UFRO-0261 | 29 | Male | Alive, not hospitalized | Two doses Sinovac | 24-10-21 | AY.122 | 21J | Delta | 37.59 | 98.65 | 1,594 | EPI_ISL_5881131 |
|
|
| AR-UFRO-0262 | 24 | Female | Alive, not hospitalized | Two doses Sinovac | 23-10-21 | AY.25.1 | 21J | Delta | 29.7 | 77.09 | 185 | EPI_ISL_5881127 |
|
|
| AR-UFRO-0263 | 35 | Male | Alive, not hospitalized | Two doses Sinovac | 19-10-21 | AY.122 | 21J | Delta | 37.65 | 98.88 | 1,649 | EPI_ISL_5881111 |
|
|
| AR-UFRO-0264 | 36 | Female | Alive, not hospitalized | Not vaccinated | 20-10-21 | AY.122 | 21J | Delta | 37.63 | 98.85 | 1,690 | EPI_ISL_5881123 |
|
|
| AR-UFRO-0265 | 12 | Male | Alive, not hospitalized | Not vaccinated | 18-10-21 | AY.122 | 21J | Delta | 37.87 | 99.53 | 1,826 | EPI_ISL_5881112 |
|
|
| AR-UFRO-0266 | 36 | Female | Alive, not hospitalized | Two doses Sinovac | 18-10-21 | AY.122 | 21J | Delta | 37.5 | 98.4 | 1,450 | EPI_ISL_5881135 |
|
|
| AR-UFRO-0267 | 36 | Male | Alive, not hospitalized | Two doses Sinovac | 18-10-21 | AY.122 | 21J | Delta | 37.65 | 98.95 | 1,719 | EPI_ISL_5881113 |
|
|
| AR-UFRO-0268 | 48 | Male | Alive, not hospitalized | Two doses Pfizer | 18-10-21 | AY.43 | 21J | Delta | 37.67 | 98.87 | 1,745 | EPI_ISL_5881114 |
|
|
| AR-UFRO-0269 | 39 | Male | Alive, not hospitalized | Two doses Sinovac | 18-10-21 | AY.122 | 21J | Delta | 37.66 | 98.87 | 1,721 | EPI_ISL_5881115 |
|
|
| AR-UFRO-0270 | 36 | Female | Alive, not hospitalized | Two doses Sinovac | 20-10-21 | AY.122 | 21J | Delta | 37.54 | 98.49 | 1,331 | EPI_ISL_5881132 |
|
|
| AR-UFRO-0271 | 21 | Male | Alive, not hospitalized | One dose CanSino | 20-10-21 | AY.101 | 21J | Delta | 37.46 | 98.36 | 1,224 | EPI_ISL_5881134 |
|
|
| AR-UFRO-0272 | 22 | Male | Alive, not hospitalized | One dose Sinovac | 20-10-21 | AY.43 | 21J | Delta | 36.94 | 96.84 | 1,113 | EPI_ISL_5924521 |
|
|
| AR-UFRO-0273 | 85 | Male | Alive, not hospitalized | Two doses Sinovac | 20-10-21 | AY.43 | 21J | Delta | 37.32 | 97.88 | 1,280 | EPI_ISL_5924519 |
|
|
| AR-UFRO-0274 | 53 | Female | Alive, not hospitalized | Two doses Sinovac | 20-10-21 | AY.43 | 21J | Delta | 37.66 | 98.84 | 1,398 | EPI_ISL_5924518 |
|
|
| AR-UFRO-0275 | 46 | Male | Alive, not hospitalized | Two doses Pfizer | 20-10-21 | AY.122 | 21J | Delta | 37.34 | 97.97 | 1,074 | EPI_ISL_5881137 |
|
|
| AR-UFRO-0276 | 13 | Female | Alive, not hospitalized | Not vaccinated | 20-10-21 | AY.122 | 21J | Delta | 37.59 | 98.75 | 1,594 | EPI_ISL_5881124 |
|
|
| AR-UFRO-0279 | 41 | Female | Alive, not hospitalized | Two doses Pfizer | 19-10-21 | AY.25.1 | 21J | Delta | 33.39 | 86.75 | 393 | EPI_ISL_5881126 |
|
|
| AR-UFRO-0285 | 35 | Female | Alive, not hospitalized | Two doses Sinovac | 20-10-21 | AY.43.3 | 21J | Delta | 36.86 | 96.98 | 1,154 | EPI_ISL_5881116 |
|
|
| AR-UFRO-0286 | 54 | Female | Alive, not hospitalized | Two doses Pfizer | 21-10-21 | AY.43.3 | 21J | Delta | 37.95 | 99.74 | 2,052 | EPI_ISL_5881116 |
|
|
| AR-UFRO-0287 | 39 | Female | Alive, not hospitalized | Two doses Sinovac | 21-10-21 | AY.25.1 | 21J | Delta | 37.94 | 99.7 | 2,151 | EPI_ISL_5881122 |
|
|
| AR-UFRO-0288 | 41 | Male | Alive, not hospitalized | Not vaccinated | 22-10-21 | AY.25.1 | 21J | Delta | 37.83 | 99.38 | 1,754 | EPI_ISL_5881117 |
|
|
| AR-UFRO-0289 | 28 | Female | Alive, not hospitalized | Not vaccinated | 21-10-21 | AY.43.3 | 21J | Delta | 37.44 | 98.46 | 1,544 | EPI_ISL_5881133 |
|
|
| AR-UFRO-0290 | 20 | Male | Alive, not hospitalized | Two doses Sinovac | 21-10-21 | AY.43.3 | 21J | Delta | 37.65 | 98.85 | 1,624 | EPI_ISL_5881118 |
|
|
| AR-UFRO-0291 | 28 | Male | Alive, not hospitalized | Two doses Sinovac | 22-10-21 | AY.43.3 | 21J | Delta | 37.92 | 99.66 | 1,788 | EPI_ISL_5881118 |
|
|
| AR-UFRO-0292 | 24 | Female | Alive, not hospitalized | Two doses Sinovac | 22-10-21 | AY.43.3 | 21J | Delta | 37.7 | 99.04 | 1,541 | EPI_ISL_5881125 |
|
|
| AR-UFRO-0293 | 10 | Female | Alive, not hospitalized | Not vaccinated | 22-10-21 | AY.25.1 | 21J | Delta | 37.25 | 97.72 | 1,325 | EPI_ISL_5881125 |
|
|
| AR-UFRO-0296 | 34 | Female | Alive, not hospitalized | Two doses Pfizer | 20-10-21 | AY.43.3 | 21J | Delta | 33.85 | 87.07 | 518 | EPI_ISL_5881125 |
|
|
| AR-UFRO-0298 | 43 | Female | Alive, not hospitalized | Two doses Sinovac | 21-10-21 | AY.122 | 21J | Delta | 34.89 | 91.24 | 669 | EPI_ISL_5881130 |
|
|
| AR-UFRO-0299 | 40 | Male | Alive, not hospitalized | Two doses Sinovac | 22-10-21 | AY.43.3 | 21J | Delta | 37.96 | 99.72 | 1,901 | EPI_ISL_5881120 |
|
|
| AR-UFRO-0300 | 10 | Male | Alive, not hospitalized | One dose Sinovac | 22-10-21 | AY.25.1 | 21J | Delta | 37.15 | 97.42 | 1,360 | EPI_ISL_5881141 |
|
|
| AR-UFRO-0301 | 65 | Male | Alive, not hospitalized | Two doses Sinovac | 22-10-21 | AY.43 | 21J | Delta | 37.21 | 97.61 | 1,043 | EPI_ISL_5924520 |
|
|
| AR-UFRO-0305 | 5 | Female | Alive, not hospitalized | Not vaccinated | 25-10-21 | AY.122 | 21J | Delta | 37.15 | 97.49 | 933 | EPI_ISL_5881140 |
|
|
| AR-UFRO-0306 | 76 | Female | Alive, not hospitalized | Not vaccinated | 25-10-21 | AY.25.1 | 21J | Delta | 37.88 | 99.4 | 1,764 | EPI_ISL_5881110 |
|
|
| AR-UFRO-0310 | 70 | Male | Hospitalized | Two doses Sinovac | 26-10-21 | AY.25.1 | 21J | Delta | 36.91 | 96.69 | 792 | EPI_ISL_6016330 |
|
|
| AR-UFRO-0311 | 23 | Female | Alive, not hospitalized | Not vaccinated | 27-10-21 | AY.25.1 | 21J | Delta | 37.18 | 97.48 | 1,223 | EPI_ISL_6016334 |
|
|
| AR-UFRO-0313 | 51 | Male | Alive, not hospitalized | Not vaccinated | 26-10-21 | AY.122 | 21J | Delta | 36.42 | 95.47 | 697 | EPI_ISL_6016168 |
|
|
| AR-UFRO-0315 | 38 | Male | Alive, not hospitalized | One dose Pfizer | 27-10-21 | AY.122 | 21J | Delta | 36.17 | 94.68 | 448 | EPI_ISL_6016162 |
|
|
| AR-UFRO-0316 | 32 | Male | Alive, not hospitalized | Two doses CanSino | 28-10-21 | AY.122 | 21J | Delta | 32.79 | 84.8 | 286 | EPI_ISL_6016344 |
|
|
| AR-UFRO-0318 | 40 | Female | Alive, not hospitalized | Two doses Sinovac | 28-10-21 | AY.25.1 | 21J | Delta | 34.97 | 90.17 | 523 | EPI_ISL_6016349 |
|
|
| AR-UFRO-0321 | 35 | Male | Alive, not hospitalized | Not vaccinated | 27-10-21 | AY.43 | 21J | Delta | 37.27 | 97.45 | 916 | EPI_ISL_6016174 |
|
|
| AR-UFRO-0322 | 66 | Female | Alive, not hospitalized | Not vaccinated | 27-10-21 | AY.43 | 21J | Delta | 37.25 | 97.37 | 1,187 | EPI_ISL_6016177 |
|
|
| AR-UFRO-0324 | 34 | Male | Alive, not hospitalized | Two doses Sinovac | 29-10-21 | AY.25.1 | 21J | Delta | 35.65 | 93.12 | 595 | EPI_ISL_6016355 |
|
|
| AR-UFRO-0327 | 54 | Female | Alive, not hospitalized | Two doses Sinovac | 29-10-21 | AY.25.1 | 21J | Delta | 37.16 | 97.43 | 1,140 | EPI_ISL_6016364 |
|
|
| AR-UFRO-0329 | 33 | Male | Alive, not hospitalized | Two doses Sinovac | 29-10-21 | AY.122 | 21J | Delta | 36.9 | 96.63 | 512 | EPI_ISL_6016181 |
|
|
| AR-UFRO-0336 | 61 | Female | Alive, not hospitalized | Two doses Sinovac | 31-10-21 | AY.25.1 | 21J | Delta | 35.06 | 91.4 | 334 | EPI_ISL_6016370 |
|
|
| AR-UFRO-0338 | 27 | Male | Alive, not hospitalized | Two doses Sinovac | 31-10-21 | AY.122 | 21J | Delta | 36.95 | 96.9 | 687 | EPI_ISL_6016377 |
|
|
| AR-UFRO-0339 | 50 | Male | Alive, not hospitalized | Not vaccinated | 01-11-21 | AY.25.1 | 21J | Delta | 37.34 | 97.94 | 1,377 | EPI_ISL_6016385 |
|
|
| AR-UFRO-0340 | 65 | Male | Hospitalized | Two doses Sinovac | 27-10-21 | AY.43 | 21J | Delta | 37.67 | 98.87 | 1,470 | EPI_ISL_6016187 |
|
|
| AR-UFRO-0342 | 30 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.119 | 21J | Delta | 37.65 | 98.84 | 1,402 | EPI_ISL_6016191 |
|
|
| AR-UFRO-0343 | 44 | Male | Hospitalized | Not vaccinated | 25-10-21 | AY.101 | 21J | Delta | 37.66 | 98.87 | 1,257 | EPI_ISL_6016124 |
|
|
| AR-UFRO-0344 | 30 | Female | Alive, not hospitalized | Two doses Sinovac | 25-10-21 | AY.43 | 21J | Delta | 37.63 | 98.29 | 1,429 | EPI_ISL_6016137 |
|
|
| AR-UFRO-0345 | 61 | Female | Hospitalized | Not vaccinated | 25-10-21 | AY.25.1 | 21J | Delta | 37.54 | 98.49 | 1,289 | EPI_ISL_6016196 |
|
|
| AR-UFRO-0350 | 37 | Male | Alive, not hospitalized | Not vaccinated | 26-10-21 | AY.102 | 21J | Delta | 37.59 | 98.74 | 1,477 | EPI_ISL_6016145 |
|
|
| AR-UFRO-0351 | 31 | Female | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.43.3 | 21J | Delta | 37.03 | 97.09 | 770 | EPI_ISL_6016151 |
|
|
| AR-UFRO-0352 | 34 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.43.3 | 21J | Delta | 37.27 | 97.72 | 1,061 | EPI_ISL_6016317 |
|
|
| AR-UFRO-0353 | 32 | Female | Hospitalized | Two doses Sinovac | 27-10-21 | AY.25.1 | 21J | Delta | 37.34 | 97.91 | 1,311 | EPI_ISL_6016202 |
|
|
| AR-UFRO-0354 | 39 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.25.1 | 21J | Delta | 37.59 | 98.68 | 1,300 | EPI_ISL_6016321 |
|
|
| AR-UFRO-0355 | 54 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.25.1 | 21J | Delta | 37.67 | 98.87 | 1,559 | EPI_ISL_6016324 |
|
|
| AR-UFRO-0356 | 35 | Male | Alive, not hospitalized | Two doses Pfizer | 28-10-21 | AY.25.1 | 21J | Delta | 37.53 | 98.43 | 1,547 | EPI_ISL_6016309 |
|
|
| AR-UFRO-0357 | 32 | Female | Hospitalized | Two doses Sinovac | 28-10-21 | AY.25.1 | 21J | Delta | 37.84 | 99.37 | 1,589 | EPI_ISL_6016209 |
|
|
| AR-UFRO-0362 | 41 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.25.1 | 21J | Delta | 36.93 | 96.71 | 893 | EPI_ISL_6016307 |
|
|
| AR-UFRO-0364 | 28 | Male | Alive, not hospitalized | Two doses Sinovac | 26-10-21 | AY.122 | 21J | Delta | 37.49 | 98.37 | 1,390 | EPI_ISL_6016218 |
|
|
| AR-UFRO-0365 | 45 | Male | Alive, not hospitalized | Two doses Sinovac | 27-10-21 | AY.122 | 21J | Delta | 37.41 | 98.18 | 1,327 | EPI_ISL_6016222 |
|
|
| AR-UFRO-0366 | 13 | Female | Alive, not hospitalized | Two doses Sinovac | 27-10-21 | AY.43.3 | 21J | Delta | 37.19 | 97.58 | 1,241 | EPI_ISL_6016230 |
|
|
| AR-UFRO-0367 | 14 | Female | Alive, not hospitalized | Two doses Pfizer | 29-10-21 | AY.43.3 | 21J | Delta | 37.25 | 97.68 | 1,171 | EPI_ISL_6016237 |
|
|
| AR-UFRO-0368 | 47 | Female | Alive, not hospitalized | Two doses Pfizer | 28-10-21 | AY.43.3 | 21J | Delta | 37.15 | 97.48 | 938 | EPI_ISL_6016244 |
|
|
| AR-UFRO-0369 | 40 | Female | Alive, not hospitalized | Two doses Sinovac | 28-10-21 | AY.43.3 | 21J | Delta | 37.66 | 98.87 | 1,413 | EPI_ISL_6016251 |
|
|
| AR-UFRO-0370 | 27 | Male | Alive, not hospitalized | Not vaccinated | 28-10-21 | AY.122 | 21J | Delta | 37.65 | 98.87 | 1,440 | EPI_ISL_6016259 |
|
|
| AR-UFRO-0371 | 40 | Female | Alive, not hospitalized | Not vaccinated | 28-10-21 | AY.43.3 | 21J | Delta | 37.75 | 99.16 | 1,612 | EPI_ISL_6016266 |
|
|
| AR-UFRO-0372 | 20 | Male | Alive, not hospitalized | One dose Pfizer | 28-10-21 | AY.122 | 21J | Delta | 37.44 | 98.27 | 1,182 | EPI_ISL_6016272 |
|
|
| AR-UFRO-0373 | 37 | Female | Alive, not hospitalized | Two doses Sinovac | 28-10-21 | AY.43.3 | 21J | Delta | 37.66 | 98.87 | 1,492 | EPI_ISL_6016277 |
|
|
| AR-UFRO-0374 | 23 | Female | Alive, not hospitalized | Two doses Pfizer | 27-10-21 | AY.119 | 21J | Delta | 37.41 | 98.13 | 1,122 | EPI_ISL_6016284 |
|
|
| AR-UFRO-0375 | 34 | Male | Alive, not hospitalized | Two doses Sinovac | 27-10-21 | AY.25.1 | 21J | Delta | 37.66 | 98.87 | 1,452 | EPI_ISL_6016288 |
|
|
| AR-UFRO-0376 | 51 | Female | Alive, not hospitalized | Two doses Pfizer | 27-10-21 | AY.119 | 21J | Delta | 37.65 | 98.85 | 1,421 | EPI_ISL_6016295 |
|
|
| AR-UFRO-0377 | 48 | Male | Alive, not hospitalized | Not vaccinated | 27-10-21 | AY.43.3 | 21J | Delta | 36.9 | 96.75 | 939 | EPI_ISL_6016299 |
|
|
| AR-UFRO-0378 | 13 | Female | Alive, not hospitalized | Not vaccinated | 27-10-21 | AY.43.3 | 21J | Delta | 36.97 | 96.98 | 873 | EPI_ISL_6016160 |
|
|
| AR-UFRO-0380 | 27 | Male | Alive, not hospitalized | Two doses CanSino | 02-11-21 | AY.25.1 | 21J | Delta | 36.22 | 95.11 | 731 | EPI_ISL_6309830 |
|
|
| AR-UFRO-0381 | 50 | Male | Alive, not hospitalized | Two doses Sinovac | 02-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.73 | 1,377 | EPI_ISL_6309831 |
|
|
| AR-UFRO-0382 | 31 | Female | Alive, not hospitalized | One dose Sinovac | 04-10-21 | AY.122 | 21J | Delta | 32.91 | 86.46 | 207 | EPI_ISL_6309832 |
|
|
| AR-UFRO-0383 | 51 | Male | Hospitalized | Two doses Sinovac | 07-10-21 | AY.25.1 | 21J | Delta | 33.56 | 88.08 | 153 | EPI_ISL_6309833 |
|
|
| AR-UFRO-0384 | 68 | Female | Alive, not hospitalized | Two doses Sinovac | 04-11-21 | AY.102 | 21J | Delta | 36.55 | 95.98 | 774 | EPI_ISL_6309834 |
|
|
| AR-UFRO-0385 | 28 | Male | Alive, not hospitalized | Two doses Pfizer | 04-11-21 | AY.25.1 | 21J | Delta | 36.84 | 96.5 | 979 | EPI_ISL_6309835 |
|
|
| AR-UFRO-0386 | 42 | Male | Alive, not hospitalized | Two doses Sinovac | 04-11-21 | AY.25.1 | 21J | Delta | 37.97 | 99.71 | 1,612 | EPI_ISL_6309836 |
|
|
| AR-UFRO-0387 | 45 | Male | Alive, not hospitalized | Two doses Sinovac | 04-11-21 | AY.25.1 | 21J | Delta | 37.68 | 98.87 | 932 | EPI_ISL_6309837 |
|
|
| AR-UFRO-0388 | 31 | Female | Alive, not hospitalized | Two doses Pfizer | 06-11-21 | AY.25.1 | 21J | Delta | 37.97 | 99.74 | 1,795 | EPI_ISL_6309838 |
|
|
| AR-UFRO-0389 | 39 | Male | Alive, not hospitalized | Two doses Sinovac | 05-11-21 | AY.43 | 21J | Delta | 37.65 | 98.85 | 1,341 | EPI_ISL_6309839 |
|
|
| AR-UFRO-0390 | 33 | Female | Alive, not hospitalized | Not vaccinated | 05-11-21 | AY.43.3 | 21J | Delta | 37.74 | 99.14 | 1,627 | EPI_ISL_6309840 |
|
|
| AR-UFRO-0391 | 16 | Male | Alive, not hospitalized | Not vaccinated | 05-11-21 | AY.43.3 | 21J | Delta | 37.69 | 98.99 | 1,239 | EPI_ISL_6309841 |
|
|
| AR-UFRO-0392 | 7 | Female | Alive, not hospitalized | Not vaccinated | 05-11-21 | AY.43.3 | 21J | Delta | 37.95 | 99.73 | 1,677 | EPI_ISL_6309842 |
|
|
| AR-UFRO-0393 | 36 | Female | Alive, not hospitalized | Two doses Pfizer | 05-11-21 | AY.101 | 21J | Delta | 31.4 | 81.66 | 111 | EPI_ISL_6309843 |
|
|
| AR-UFRO-0394 | 42 | Female | Alive, not hospitalized | Two doses Pfizer | 05-11-21 | AY.25.1 | 21J | Delta | 37.98 | 99.75 | 1,996 | EPI_ISL_6309844 |
|
|
| AR-UFRO-0395 | 54 | Male | Alive, not hospitalized | Two doses Pfizer | 06-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.86 | 1,261 | EPI_ISL_6309845 |
|
|
| AR-UFRO-0396 | 88 | Female | Hospitalized | Two doses Sinovac | 06-11-21 | AY.25.1 | 21J | Delta | 37.97 | 99.74 | 2,094 | EPI_ISL_6309846 |
|
|
| AR-UFRO-0397 | 26 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.43.3 | 21J | Delta | 37.95 | 99.72 | 1,885 | EPI_ISL_6309847 |
|
|
| AR-UFRO-0398 | 37 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.43.3 | 21J | Delta | 37.81 | 99.32 | 1,513 | EPI_ISL_6309848 |
|
|
| AR-UFRO-0399 | 24 | Male | Alive, not hospitalized | Not vaccinated | 06-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.73 | 1,788 | EPI_ISL_6309849 |
|
|
| AR-UFRO-0400 | 6 | Male | Alive, not hospitalized | Not vaccinated | 06-11-21 | AY.101 | 21J | Delta | 37.9 | 99.58 | 1,718 | EPI_ISL_6309850 |
|
|
| AR-UFRO-0401 | 37 | Female | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.100 | 21J | Delta | 37.95 | 99.74 | 1,988 | EPI_ISL_6309851 |
|
|
| AR-UFRO-0402 | 22 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.43.3 | 21J | Delta | 37.87 | 99.47 | 1,495 | EPI_ISL_6309852 |
|
|
| AR-UFRO-0403 | 44 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.100 | 21J | Delta | 37.89 | 99.51 | 1,449 | EPI_ISL_6309853 |
|
|
| AR-UFRO-0404 | 48 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.73 | 1,899 | EPI_ISL_6309854 |
|
|
| AR-UFRO-0405 | 28 | Female | Alive, not hospitalized | Not vaccinated | 06-11-21 | AY.102 | 21J | Delta | 37.96 | 99.73 | 1,866 | EPI_ISL_6309855 |
|
|
| AR-UFRO-0406 | 58 | Female | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.25.1 | 21J | Delta | 37.66 | 98.86 | 1,368 | EPI_ISL_6309856 |
|
|
| AR-UFRO-0407 | 63 | Female | Alive, not hospitalized | Two doses Sinovac | 05-11-21 | AY.25.1 | 21J | Delta | 37.67 | 98.84 | 1,143 | EPI_ISL_6309857 |
|
|
| AR-UFRO-0408 | 41 | Male | Alive, not hospitalized | Two doses Sinovac | 06-11-21 | AY.43 | 21J | Delta | 37.66 | 98.87 | 1,460 | EPI_ISL_6309858 |
|
|
| AR-UFRO-0409 | 35 | Male | Alive, not hospitalized | Two doses CanSino | 05-11-21 | AY.43.3 | 21J | Delta | 37.64 | 98.84 | 1,225 | EPI_ISL_6309859 |
|
|
| AR-UFRO-0410 | 25 | Female | Alive, not hospitalized | Two doses Sinovac | 05-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.74 | 1,553 | EPI_ISL_6309860 |
|
|
| AR-UFRO-0411 | 86 | Male | Alive, not hospitalized | Not vaccinated | 05-11-21 | AY.102 | 21J | Delta | 37.96 | 99.73 | 1,547 | EPI_ISL_6309861 |
|
|
| AR-UFRO-0412 | 55 | Male | Alive, not hospitalized | Two doses Sinovac | 05-11-21 | AY.122 | 21J | Delta | 37.64 | 98.87 | 1,222 | EPI_ISL_6309862 |
|
|
| AR-UFRO-0413 | 9 | Female | Alive, not hospitalized | One dose Sinovac | 06-11-21 | AY.43.3 | 21J | Delta | 36.19 | 95.02 | 838 | EPI_ISL_6309863 |
|
|
| AR-UFRO-0414 | 5 | Male | Alive, not hospitalized | Not vaccinated | 07-11-21 | AY.102 | 21J | Delta | 37.94 | 99.68 | 1,725 | EPI_ISL_6309864 |
|
|
| AR-UFRO-0415 | 63 | Male | Alive, not hospitalized | Two doses Pfizer | 07-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.74 | 1,559 | EPI_ISL_6309865 |
|
|
| AR-UFRO-0416 | 53 | Male | Alive, not hospitalized | Two doses Sinovac | 07-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.73 | 1,684 | EPI_ISL_6309866 |
|
|
| AR-UFRO-0417 | 22 | Female | Alive, not hospitalized | Two doses Sinovac | 07-11-21 | AY.43.3 | 21J | Delta | 37.95 | 99.71 | 1,542 | EPI_ISL_6309867 |
|
|
| AR-UFRO-0418 | 28 | Male | Alive, not hospitalized | Not vaccinated | 07-11-21 | AY.43.3 | 21J | Delta | 37.95 | 99.69 | 1,349 | EPI_ISL_6309868 |
|
|
| AR-UFRO-0419 | 37 | Male | Alive, not hospitalized | Two doses Sinovac | 07-11-21 | AY.43 | 21J | Delta | 37.94 | 99.65 | 1,190 | EPI_ISL_6309869 |
|
|
| AR-UFRO-0420 | 31 | Female | Alive, not hospitalized | Two doses Sinovac | 07-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.74 | 1,556 | EPI_ISL_6309870 |
|
|
| AR-UFRO-0421 | 27 | Female | Alive, not hospitalized | One dose Pfizer | 06-11-21 | AY.101 | 21J | Delta | 37.96 | 99.71 | 1,466 | EPI_ISL_6309871 |
|
|
| AR-UFRO-0422 | 69 | Male | Hospitalized | Two doses Sinovac | 06-11-21 | AY.101 | 21J | Delta | 37.96 | 99.74 | 1,728 | EPI_ISL_6309872 |
|
|
| AR-UFRO-0423 | 22 | Female | Alive, not hospitalized | Two doses CanSino | 09-11-21 | AY.119.1 | 21J | Delta | 37.64 | 98.94 | 1,389 | EPI_ISL_6605781 |
|
|
| AR-UFRO-0424 | 77 | Male | Alive, not hospitalized | Two doses Sinovac | 09-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.85 | 1,571 | EPI_ISL_6605787 |
|
|
| AR-UFRO-0425 | 23 | Male | Hospitalized | Two doses Sinovac | 11-11-21 | AY.43.3 | 21J | Delta | 37.25 | 97.67 | 767 | EPI_ISL_6605794 |
|
|
| AR-UFRO-0426 | 25 | Female | Alive, not hospitalized | One dose Pfizer | 09-11-21 | AY.43.3 | 21J | Delta | 37.36 | 98.06 | 1,180 | EPI_ISL_6605802 |
|
|
| AR-UFRO-0427 | 60 | Male | Alive, not hospitalized | Two doses Sinovac | 10-11-21 | AY.25.1 | 21J | Delta | 37.53 | 98.39 | 1,347 | EPI_ISL_6605812 |
|
|
| AR-UFRO-0428 | 53 | Male | Alive, not hospitalized | Two doses Pfizer | 09-11-21 | AY.25.1 | 21J | Delta | 37.74 | 99.04 | 1,498 | EPI_ISL_6605816 |
|
|
| AR-UFRO-0429 | 51 | Female | Alive, not hospitalized | Two doses Sinovac | 10-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,736 | EPI_ISL_6605825 |
|
|
| AR-UFRO-0430 | 45 | Male | Alive, not hospitalized | Two doses Pfizer | 10-11-21 | AY.102 | 21J | Delta | 37.64 | 98.84 | 1744 | EPI_ISL_6605832 |
|
|
| AR-UFRO-0431 | 53 | Female | Alive, not hospitalized | Two doses Sinovac | 11-11-21 | AY.43.3 | 21J | Delta | 37.66 | 98.84 | 1,410 | EPI_ISL_6605840 |
|
|
| AR-UFRO-0432 | 36 | Male | Alive, not hospitalized | Not vaccinated | 09-11-21 | AY.43 | 21J | Delta | 37.47 | 98.04 | 996 | EPI_ISL_6605846 |
|
|
| AR-UFRO-0433 | 38 | Female | Alive, not hospitalized | Not vaccinated | 09-11-21 | AY.43 | 21J | Delta | 37.68 | 98.65 | 1,581 | EPI_ISL_6605853 |
|
|
| AR-UFRO-0434 | 63 | Female | Alive, not hospitalized | Two doses Sinovac | 10-11-21 | AY.43 | 21J | Delta | 37.95 | 99.7 | 1,530 | EPI_ISL_6722292 |
|
|
| AR-UFRO-0435 | 18 | Female | Alive, not hospitalized | Two doses Pfizer | 09-11-21 | AY.25.1 | 21J | Delta | 37.67 | 98.84 | 1,503 | EPI_ISL_6605861 |
|
|
| AR-UFRO-0436 | 27 | Female | Alive, not hospitalized | Two doses Sinovac | 08-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,599 | EPI_ISL_6605869 |
|
|
| AR-UFRO-0437 | 34 | Male | Alive, not hospitalized | Two doses Sinovac | 09-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.84 | 1,380 | EPI_ISL_6605879 |
|
|
| AR-UFRO-0438 | 24 | Male | Hospitalized | Not vaccinated | 12-11-21 | AY.43.3 | 21J | Delta | 37.12 | 97.3 | 935 | EPI_ISL_6605886 |
|
|
| AR-UFRO-0439 | 56 | Male | Alive, not hospitalized | Two doses Sinovac | 10-11-21 | AY.101 | 21J | Delta | 37.66 | 98.84 | 1,581 | EPI_ISL_6605895 |
|
|
| AR-UFRO-0440 | 50 | Female | Alive, not hospitalized | Two doses Pfizer | 10-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.74 | 1,706 | EPI_ISL_6605903 |
|
|
| AR-UFRO-0441 | 39 | Male | Alive, not hospitalized | Two doses Sinovac | 11-11-21 | AY.43 | 21J | Delta | 37.65 | 98.89 | 1,371 | EPI_ISL_6605910 |
|
|
| AR-UFRO-0442 | 23 | Female | Alive, not hospitalized | Two doses Pfizer | 11-11-21 | AY.43.3 | 21J | Delta | 37.94 | 99.68 | 1,695 | EPI_ISL_6605915 |
|
|
| AR-UFRO-0443 | 22 | Female | Alive, not hospitalized | One dose Sinovac | 11-11-21 | AY.43.3 | 21J | Delta | 37.18 | 97.63 | 1,013 | EPI_ISL_6605925 |
|
|
| AR-UFRO-0444 | 19 | Female | Alive, not hospitalized | Two doses Pfizer | 12-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.88 | 1,311 | EPI_ISL_6605934 |
|
|
| AR-UFRO-0445 | 24 | Male | Alive, not hospitalized | Two doses Pfizer | 12-11-21 | AY.43.3 | 21J | Delta | 37.34 | 97.95 | 1,081 | EPI_ISL_6605940 |
|
|
| AR-UFRO-0446 | 54 | Female | Alive, not hospitalized | Not vaccinated | 12-11-21 | AY.119.1 | 21J | Delta | 37.92 | 99.59 | 1,493 | EPI_ISL_6605951 |
|
|
| AR-UFRO-0447 | 36 | Male | Alive, not hospitalized | Two doses Pfizer | 13-11-21 | AY.25.1 | 21J | Delta | 37.39 | 98.06 | 1,122 | EPI_ISL_6605955 |
|
|
| AR-UFRO-0448 | 7 | Female | Alive, not hospitalized | One dose Sinovac | 12-11-21 | AY.25.1 | 21J | Delta | 37.45 | 98.2 | 1,146 | EPI_ISL_6605963 |
|
|
| AR-UFRO-0449 | 23 | Female | Alive, not hospitalized | Two doses Sinovac | 13-11-21 | AY.43.3 | 21J | Delta | 37.6 | 98.79 | 1,237 | EPI_ISL_6605971 |
|
|
| AR-UFRO-0450 | 12 | Male | Alive, not hospitalized | One dose Sinovac | 13-11-21 | AY.101 | 21J | Delta | 37.83 | 99.46 | 1,543 | EPI_ISL_6605977 |
|
|
| AR-UFRO-0451 | 25 | Female | Alive, not hospitalized | Two doses Sinovac | 13-11-21 | AY.102 | 21J | Delta | 37.65 | 98.88 | 1,320 | EPI_ISL_6605986 |
|
|
| AR-UFRO-0452 | 41 | Female | Alive, not hospitalized | Two doses Sinovac | 13-11-21 | AY.25.1 | 21J | Delta | 37.66 | 98.79 | 1,208 | EPI_ISL_6605990 |
|
|
| AR-UFRO-0453 | 48 | Female | Alive, not hospitalized | Two doses Sinovac | 12-11-21 | AY.43.3 | 21J | Delta | 37.34 | 97.97 | 1,013 | EPI_ISL_6605999 |
|
|
| AR-UFRO-0454 | 48 | Female | Alive, not hospitalized | Two doses Sinovac | 14-11-21 | AY.101 | 21J | Delta | 37.95 | 99.7 | 1,583 | EPI_ISL_6606011 |
|
|
| AR-UFRO-0455 | 29 | Male | Alive, not hospitalized | Two doses Sinovac | 14-11-21 | AY.102 | 21J | Delta | 37.65 | 98.83 | 1,189 | EPI_ISL_6606018 |
|
|
| AR-UFRO-0456 | 20 | Male | Hospitalized | Not vaccinated | 14-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.93 | 1,572 | EPI_ISL_6606025 |
|
|
| AR-UFRO-0457 | 52 | Female | Hospitalized | Not vaccinated | 14-11-21 | AY.43.3 | 21J | Delta | 37.66 | 98.91 | 1,484 | EPI_ISL_6606031 |
|
|
| AR-UFRO-0459 | 8 | Male | Alive, not hospitalized | Not vaccinated | 12-11-21 | AY.25.1 | 21J | Delta | 37.48 | 98.39 | 1,337 | EPI_ISL_6606041 |
|
|
| AR-UFRO-0460 | 31 | Male | Alive, not hospitalized | Two doses Sinovac | 18-11-21 | AY.101 | 21J | Delta | 37.96 | 99.71 | 1,443 | EPI_ISL_7698030 |
|
|
| AR-UFRO-0461 | 32 | Female | Hospitalized | Two doses Sinovac | 21-11-21 | AY.25.1 | 21J | Delta | 37.9 | 99.53 | 1,363 | EPI_ISL_7698032 |
|
|
| AR-UFRO-0462 | 86 | Female | Hospitalized | Two doses Sinovac | 19-11-21 | AY.43.3 | 21J | Delta | 37.87 | 99.44 | 1,272 | EPI_ISL_7698033 |
|
|
| AR-UFRO-0463 | 60 | Male | Hospitalized | Two doses AstraZeneca | 17-11-21 | AY.102 | 21J | Delta | 36.99 | 97.37 | 537 | EPI_ISL_7698034 |
|
|
| AR-UFRO-0464 | 25 | Female | Hospitalized | Not vaccinated | 17-11-21 | AY.25.1 | 21J | Delta | 37.67 | 99.07 | 843 | EPI_ISL_7698038 |
|
|
| AR-UFRO-0465 | 24 | Male | Alive, not hospitalized | Two doses Sinovac | 19-11-21 | AY.25.1 | 21J | Delta | 37.68 | 98.92 | 1,388 | EPI_ISL_7698040 |
|
|
| AR-UFRO-0466 | 53 | Male | Alive, not hospitalized | Two doses Sinovac | 19-11-21 | AY.122 | 21J | Delta | 37.94 | 99.81 | 1,690 | EPI_ISL_7698043 |
|
|
| AR-UFRO-0467 | 30 | Male | Alive, not hospitalized | Two doses Sinovac | 18-11-21 | AY.122 | 21J | Delta | 37.34 | 98.06 | 690 | EPI_ISL_7698045 |
|
|
| AR-UFRO-0468 | 56 | Female | Hospitalized | Two doses Sinovac | 22-11-21 | AY.122 | 21J | Delta | 37.94 | 99.71 | 1,288 | EPI_ISL_7698048 |
|
|
| AR-UFRO-0469 | 23 | Male | Alive, not hospitalized | Two doses Sinovac | 21-11-21 | AY.43.3 | 21J | Delta | 37.88 | 99.51 | 1,217 | EPI_ISL_7698050 |
|
|
| AR-UFRO-0470 | 39 | Female | Alive, not hospitalized | One dose Sinovac | 19-11-21 | AY.43 | 21J | Delta | 35.63 | 93.53 | 456 | EPI_ISL_7698053 |
|
|
| AR-UFRO-0473 | 27 | Female | Alive, not hospitalized | Two doses Sinovac | 22-11-21 | AY.43.3 | 21J | Delta | 37.6 | 98.69 | 842 | EPI_ISL_7698055 |
|
|
| AR-UFRO-0474 | 49 | Male | Alive, not hospitalized | Two doses Sinovac | 28-11-21 | AY.25.1 | 21J | Delta | 35.14 | 92.26 | 487 | EPI_ISL_7698057 |
|
|
| AR-UFRO-0477 | 29 | Male | Alive, not hospitalized | Two doses Sinovac | 27-11-21 | AY.43.3 | 21J | Delta | 37.87 | 99.46 | 1,025 | EPI_ISL_7698060 |
|
|
| AR-UFRO-0478 | 54 | Female | Alive, not hospitalized | Not vaccinated | 26-11-21 | AY.122 | 21J | Delta | 37.82 | 99.27 | 1,194 | EPI_ISL_7698062 |
|
|
| AR-UFRO-0479 | 21 | Female | Alive, not hospitalized | Two doses Pfizer | 26-11-21 | AY.43.3 | 21J | Delta | 37.96 | 99.82 | 1,540 | EPI_ISL_7698065 |
|
|
| AR-UFRO-0480 | 71 | Female | Alive, not hospitalized | Two doses Sinovac | 26-11-21 | AY.43.3 | 21J | Delta | 37.65 | 98.85 | 1,065 | EPI_ISL_7698067 |
|
|
| AR-UFRO-0481 | 18 | Male | Alive, not hospitalized | Two doses Sinovac | 26-11-21 | AY.43.3 | 21J | Delta | 37.84 | 99.52 | 1,027 | EPI_ISL_7698070 |
|
|
| AR-UFRO-0482 | 63 | Male | Alive, not hospitalized | Two doses Sinovac | 27-11-21 | AY.122 | 21J | Delta | 37.94 | 99.8 | 1,407 | EPI_ISL_7698073 |
|
|
| AR-UFRO-0483 | 75 | Female | Alive, not hospitalized | Two doses Sinovac | 26-11-21 | AY.43 | 21J | Delta | 37.79 | 98.93 | 883 | EPI_ISL_7698075 |
|
|
| AR-UFRO-0484 | 28 | Male | Alive, not hospitalized | Two doses Sinovac | 28-11-21 | AY.122 | 21J | Delta | 37.95 | 99.73 | 1,502 | EPI_ISL_7698077 |
|
|
| AR-UFRO-0485 | 49 | Male | Alive, not hospitalized | Two doses Sinovac | 29-11-21 | AY.102 | 21J | Delta | 37.95 | 99.83 | 1,718 | EPI_ISL_7698080 |
|
|
| AR-UFRO-0486 | 10 | Female | Alive, not hospitalized | One dose Sinovac | 29-11-21 | AY.122 | 21J | Delta | 37.96 | 99.82 | 1,427 | EPI_ISL_7698082 |
|
|
| AR-UFRO-0487 | 26 | Female | Alive, not hospitalized | Two doses CanSino | 29-11-21 | AY.43.3 | 21J | Delta | 37.9 | 99.58 | 1,372 | EPI_ISL_7698085 |
|
|
| AR-UFRO-0488 | 26 | Male | Alive, not hospitalized | Two doses Sinovac | 01-12-21 | AY.43.3 | 21J | Delta | 37.67 | 98.81 | 937 | EPI_ISL_7698087 |
|
|
| AR-UFRO-0489 | 30 | Male | Alive, not hospitalized | Two doses CanSino | 04-12-21 | AY.43.3 | 21J | Delta | 37.81 | 99.25 | 1,140 | EPI_ISL_7698089 |
|
|
| AR-UFRO-0490 | 25 | Female | Alive, not hospitalized | Two doses Pfizer | 04-12-21 | AY.122 | 21J | Delta | 37.94 | 99.68 | 1,409 | EPI_ISL_7698092 |
|
|
| AR-UFRO-0491 | 68 | Male | Alive, not hospitalized | Two doses Sinovac | 04-12-21 | AY.43.3 | 21J | Delta | 37.96 | 99.73 | 1,535 | EPI_ISL_7698094 |
|
|
| AR-UFRO-0492 | 34 | Male | Alive, not hospitalized | Two doses Sinovac | 05-12-21 | AY.43.3 | 21J | Delta | 37.91 | 99.83 | 1,434 | EPI_ISL_7698096 |
|
|
| AR-UFRO-0493 | 56 | Female | Alive, not hospitalized | Two doses Sinovac | 04-12-21 | AY.43.3 | 21J | Delta | 37.56 | 98.66 | 1,089 | EPI_ISL_7698098 |
|
|
| AR-UFRO-0494 | 27 | Male | Alive, not hospitalized | Two doses Sinovac | 04-12-21 | AY.25.1 | 21J | Delta | 37.91 | 99.52 | 1,347 | EPI_ISL_7698100 |
|
|
| AR-UFRO-0495 | 34 | Female | Alive, not hospitalized | Two doses Sinovac | 04-12-21 | AY.25.1 | 21J | Delta | 37.66 | 98.84 | 1,094 | EPI_ISL_7698103 |
|
|
| AR-UFRO-0496 | 18 | Female | Alive, not hospitalized | Two doses Sinovac | 04-12-21 | AY.43.3 | 21J | Delta | 37.96 | 99.72 | 1,380 | EPI_ISL_7698105 |
|
|
| AR-UFRO-0497 | 33 | Male | Alive, not hospitalized | Not vaccinated | 04-12-21 | AY.122 | 21J | Delta | 37.94 | 99.73 | 1,414 | EPI_ISL_7698107 |
|
|
| AR-UFRO-0499 | 24 | Male | Alive, not hospitalized | Two doses Sinovac | 02-12-21 | AY.25.1 | 21J | Delta | 37.97 | 99.8 | 1,579 | EPI_ISL_7698110 |
|
|
| AR-UFRO-0500 | 47 | Male | Alive, not hospitalized | Two doses Pfizer | 06-12-21 | AY.43 | 21J | Delta | 37.75 | 99.25 | 968 | EPI_ISL_7774637 |
|
|
| AR-UFRO-0501 | 25 | Male | Alive, not hospitalized | Not vaccinated | 06-12-21 | AY.43.3 | 21J | Delta | 37.95 | 99.8 | 1,153 | EPI_ISL_7698112 |
|
|
| AR-UFRO-0502 | 42 | Female | Alive, not hospitalized | Two doses Sinovac | 06-12-21 | AY.43.3 | 21J | Delta | 36.31 | 95.38 | 638 | EPI_ISL_7698115 |
|
|
ID, identifier.
day-mo-yr.